Prednisolone Biogaran

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Prednisolone Biogaran

Quick Facts

Property Description
Active ingredient Prednisolone (often as Prednisolone Acetate)
Form Oral tablet, Oral solution
Pharmacological class Glucocorticoid, Corticosteroid
General purpose Anti-inflammatory and Immunosuppressive Relief
Origin Synthetic
Status Prescription-only medicine (POM)

What Type of Medicine is Prednisolone Biogaran?

The essential component in Prednisolone Biogaran is prednisolone, a synthetic substance classified pharmacologically as a glucocorticoid, belonging to the larger family of corticosteroids. This substance functionally mimics cortisol, a natural hormone that helps the body regulate stress, metabolism, and immune responses. As a generic medicine produced by the Biogaran company, it represents an accessible formulation of prednisolone, widely available under the supervision of a healthcare professional. Prednisolone is utilized for achieving systemic regulatory control across various organ systems.


Composition and Form: The Prednisolone Entity

Prednisolone Biogaran is a single-ingredient product, leveraging prednisolone as its sole active ingredient. The compound is typically formulated as a stable salt, such as Prednisolone Acetate, within a non-active base of excipients. The medicine is designed for oral administration and is consequently available as an oral preparation, commonly in the form of a tablet or an oral solution. This delivery method ensures a systemic effect, meaning the compound is absorbed from the digestive tract and distributed throughout the entire body to deliver its therapeutic actions comprehensively.


General Purpose: Anti-inflammatory and Immunosuppressive Relief

The fundamental purpose of prednisolone is to provide systemic relief by employing two powerful physiological actions: its anti-inflammatory effect and its immunosuppressive effect. As an anti-inflammatory agent, it addresses conditions involving severe inflammation, rapidly mitigating associated symptoms like swelling and tissue redness. Concurrently, it acts as an immunosuppressant, modulating the function of immune cells to control situations where the body's immune system is pathologically hyperactive. This dual mechanism allows the compound to exert comprehensive control over inflammatory and autoimmune responses.

Regulatory References

  1. Prednisolone: MedlinePlus Drug Information
Advertisements

What side effects are possible with Prednisolone Biogaran?

Possible Side Effects and Safety Information

The safety profile for prednisolone is characterized by adverse reactions classified into specific organ systems and linked to treatment duration, as outlined in official regulatory documents. Safety concerns are grouped by System-Organ Classes, including Endocrine Disorders, Metabolism and Nutrition Disorders, and Musculoskeletal Disorders.

Classification Common Adverse Reactions
Metabolism / Endocrine Fluid retention, weight gain, impaired glucose tolerance, Cushingoid features (moon face)
Cardiovascular / Vascular Hypertension (high blood pressure)
Musculoskeletal Muscle weakness (myopathy), Osteoporosis
Nervous / Psychiatric Mood swings, nervousness, insomnia, headache

Serious adverse reactions documented in regulatory sources include the risk of Acute Adrenal Insufficiency/Crisis upon abrupt cessation of prolonged treatment, Peptic Ulcer with potential for hemorrhage, and Severe Psychiatric Disturbances. The labels also note Aseptic Necrosis (osteonecrosis) and certain Ophthalmic Effects such as posterior subcapsular cataracts and glaucoma.

Duration-Related Safety Patterns indicate that effects like osteoporosis and the full development of Cushingoid features are typically associated with long-term use. Furthermore, official labeling requires caution for specific groups: Older Adults may face an increased risk of severe effects like osteoporosis and hypertension, while the Pediatric Population carries a documented risk of growth retardation with long-term use. The medicine is formally contraindicated in patients with Systemic Fungal Infections.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The following information is based strictly on official regulatory prescribing information for prednisolone.

Acute Overdose Profile

Official regulatory documents indicate that a single, acute overdose of prednisolone is generally not expected to produce life-threatening symptoms. The clinical features most frequently associated with an acute overdosage are minor disturbances in the body’s fluid and electrolyte balance.

More serious, long-term toxic effects, such as Cushingoid features (e.g., thinning skin, changes in body fat distribution), are typically associated with the chronic use of high doses over an extended period.

Required Emergency Action

Immediate medical attention must be sought if an overdose is suspected or if too much prednisolone is taken. Patients or caregivers are instructed in official labeling to call a physician, a Poison Control Center, or emergency services (e.g., 999 or 112) immediately, or to go to the nearest emergency department.

Management and Monitoring

Management of prednisolone overdose is generally supportive and symptomatic as no specific chemical antidote is typically listed in official documents. Medical professionals may focus on monitoring for and correcting fluid and electrolyte disturbances. Monitoring of the heart rhythm (such as by ECG) may be relevant due to the potential for electrolyte imbalances.

Advertisements

Therapeutic Uses of Prednisolone Biogaran

The medicine is generally relevant for managing a wide range of conditions characterized by systemic inflammation and immune activity.

Easing Systemic and Joint Discomfort During Flare-ups

Prednisolone Biogaran is applied across domains where additional symptomatic support is needed in conditions like Rheumatoid Arthritis, Systemic Lupus Erythematosus (Lupus), and Inflammatory Bowel Diseases (IBD), as well as severe allergic and respiratory conditions such as asthma exacerbations and angioedema. It is commonly used during acute symptomatic episodes to help address symptoms related to swelling, tenderness, and pain, offering symptomatic relief that helps patients cope more steadily with difficult disease flare-ups. This approach supports patients during phases when symptoms become more noticeable.

“This medicine is commonly used when short-term symptomatic assistance is needed to manage the symptoms of a flare-up of a chronic inflammatory condition.”

Supportive Care in Specialized Conditions and Hormone Support

The medicine is relevant for easing inflammation localized in sensitive organs, such as severe eye inflammation (like uveitis), or serving as essential hormone replacement therapy for Adrenocortical Insufficiency. It is used across therapeutic domains where short-term symptomatic assistance or physiological substitution is required, assisting with symptomatic stability.


Quick Fact: Relief for Systemic Inflammation

Area of Use Symptom Focus Key Benefit
Autoimmune/Joint Swelling, joint stiffness, pain Helps ease the overall symptom load
Respiratory/Allergy Airway swelling, breathing difficulty Contributes to improved comfort during periods of heightened symptoms
Endocrine/Ophthalmic Hormonal deficit, organ-specific inflammation Assists with symptomatic stability
Advertisements

Eligibility and Restrictions for Use

Prednisolone Biogaran, containing the active ingredient prednisolone, is subject to strict eligibility rules defined by official regulatory bodies. The medicine is contraindicated and must not be used by patients with systemic fungal infections or those with a confirmed hypersensitivity to prednisolone or any of its components.

Use is restricted and requires caution and increased surveillance in several populations. These include patients with a history of recent myocardial infarction, congestive heart failure, hypertension, or gastrointestinal conditions such as an active peptic ulcer or diverticulitis. Caution is also mandated for those with ocular herpes simplex or latent tuberculosis.

Age-related eligibility requires special consideration: Pediatric patients receiving long-term treatment must be closely monitored for growth suppression. Older adults require increased supervision due to a higher risk of adverse consequences, such as osteoporosis.

Reproductive eligibility is conditional: use during pregnancy (especially the first trimester) and lactation requires a formal risk-benefit assessment by a healthcare professional, as the compound passes into breast milk and carries a documented risk of fetal harm.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration of prednisolone with other medicines requires careful consideration due to documented effects on metabolism and physiological systems.

Exposure-Modifying Agents (Pharmacokinetic)

Interacting Substance Category Effect on Prednisolone Practical Implication
CYP3A4 Inhibitors (e.g., Cobicistat, Ketoconazole) Increased systemic exposure Increased risk of corticosteroid-related side effects.
CYP3A4 Inducers (e.g., Rifampin, Phenytoin) Decreased plasma levels Potential loss of therapeutic efficacy.

Pharmacodynamic Interactions

Interacting Substance Category Resulting Pharmacodynamic Effect
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Increased risk of gastrointestinal side effects, including ulceration.
Potassium-Lowering Agents (e.g., certain diuretics, Amphotericin B) Increased risk of hypokalemia (low potassium levels).
Antidiabetic Agents Prednisolone may increase blood glucose concentrations, potentially reducing the effectiveness of antidiabetic medicines.
Anticoagulants (e.g., Warfarin) Alteration of the anticoagulant effect, requiring close monitoring of coagulation indices.

Patients with hepatic disease (cirrhosis) may experience an enhanced effect of prednisolone due to impaired elimination. Concomitant use with live or attenuated vaccines is generally avoided as the corticosteroid may suppress the immune response.

Advertisements

Mechanism of Action

How Prednisolone Biogaran Works

Prednisolone acts as a synthetic glucocorticoid primarily through two complementary pathways. First, it targets the intracellular glucocorticoid receptors (GRs), forming a ligand-receptor complex that translocates to the nucleus. This complex binds to specific DNA sequences, modulating gene transcription. This cascade results in the transcriptional suppression of specific pro-inflammatory genes (including those for cytokines) and the concurrent increased expression of anti-inflammatory genes.

Second, the molecule engages in rapid, non-genomic regulation of cellular processes. A key mechanism involves the inhibition of the enzyme phospholipase A2 (PLA2). Blocking PLA2 prevents the initiation of the arachidonic acid cascade, consequently reducing the synthesis of powerful pro-inflammatory lipid mediators like prostaglandins and leukotrienes.

At a systemic level, the drug modulates immune cell distribution and function. It promotes the apoptosis (programmed cell death) of certain immune cell subsets (e.g., T-cells and B-cells) and inhibits the extravasation and migration of neutrophils and other leukocytes out of the vasculature, altering immune cell circulation within tissues.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Prednisolone Biogaran is an oral preparation (tablet or solution) that is administered according to standardized specifications. Dosing is highly individualized but follows standardized ranges established in official prescribing information.


Dosing and Frequency

The initial adult dose generally ranges from 5 mg to 60 mg per day. Once a satisfactory response is noted, the dosage is reduced to the lowest effective maintenance dose (often 5 mg to 20 mg daily).

Administration is typically as a single dose in the morning, which helps align with the body’s natural cortisol rhythm. Higher total daily doses may be divided into two to four smaller administrations throughout the day, or may be scheduled as alternate day therapy (a double dose every other morning) for long-term use.


Administration Conditions and Duration

Administration Rule Official Instruction
Timing and Intake Take with food or milk to minimize the potential for gastrointestinal irritation.
Pediatric Dosing Dose requirements are based on body weight or body surface area, rather than strict age adherence.
Form Preparation Oral solutions must be measured with a calibrated device. Effervescent tablets must be dissolved completely in water before ingestion.
Discontinuation The medicine must be withdrawn gradually after prolonged use (generally defined as more than three weeks) or high-dose therapy. Abrupt cessation is strongly discouraged.
Missed Dose If a dose is missed, take it as soon as remembered. If it is nearly time for the next scheduled dose, the missed dose should be skipped and the regular schedule resumed; do not take a double dose.

These instructions constitute the standardized framework for the product's official use, establishing the required route, dosing schedule, and procedural steps for administration.

Advertisements

Recent Clinical Evidence

Prednisolone is a synthetic corticosteroid widely used to address a variety of inflammatory and autoimmune conditions. Clinical research in this area focuses on its anti-inflammatory and immunosuppressive properties across multiple therapeutic areas.

Research on Inflammatory and Autoimmune Conditions

Studies have been conducted to evaluate the effects of prednisolone across its licensed uses, which include conditions such as rheumatoid arthritis, severe asthma, allergic reactions, and various dermatologic disorders. Research primarily investigates how the drug's action—involving the modulation of immune activity—can affect indicators of inflammation and disease severity.

  • Monotherapy: Phase III randomized, controlled trials (RCTs) have assessed prednisolone as a standalone treatment, often focusing on metrics like the reduction of disease activity scores or the control of acute exacerbations, such as in asthma.
  • Combination Therapy: Studies frequently evaluate the co-administration of prednisolone with other standard therapies to investigate potential associated changes in patient outcomes, particularly in chronic diseases requiring multi-drug regimens.

Safety and Dosing Data

Clinical trials provide data regarding the safety and tolerability of the drug. Researchers analyze safety profiles over both short-term use for acute conditions and extended periods for chronic management. Observed findings include data on effects such as fluid retention, changes in blood sugar, and potential for increased appetite.

Research also evaluates various dose regimens. Analyses focused on potential differences between various milligram strengths, reporting on the relationship between dose and observed adverse events. For instance, data were collected on comparative profiles against older treatments in terms of discontinuations due to side effects.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Prednisolone Biogaran (FAQ)


Q: How quickly can someone expect Prednisolone Biogaran to start working?

According to official product information, the onset of action for oral prednisolone is generally considered rapid. However, the time it takes for a person to experience noticeable or significant relief from their symptoms can vary depending on the medical condition being treated and the individual's specific response.


Q: Is it common to gain weight while taking Prednisolone Biogaran?

Official regulatory documents list weight gain as a common adverse reaction associated with this medication. This effect is often linked to the drug's documented actions, which can include both fluid retention and an increase in appetite.


Q: Why does my doctor recommend taking Prednisolone Biogaran in the morning?

Official administration guidance frequently suggests taking the medicine as a single dose in the morning. This timing is intended to align the dosage with the body's natural production rhythm of the hormone cortisol, a practice that may help in managing potential effects, as it aligns with the body's natural cycle.


Q: Can Prednisolone Biogaran interact with supplements or herbal remedies?

Regulatory sources generally focus on interactions with prescription medicines, and specific data on most herbal remedies or supplements are typically limited. Official guidance advises disclosing all supplements and herbal products to a healthcare professional when discussing the medicine.


Q: Does Prednisolone Biogaran need to be taken with food?

Yes, official regulatory guidelines state that this medication should be taken with food or milk. This condition is primarily in place to help minimize the potential for gastrointestinal irritation or stomach discomfort, which is a known possibility with the medicine.


Q: Is Prednisolone Biogaran the same as other prednisolone tablets?

The active ingredient in Prednisolone Biogaran is prednisolone, which is the drug entity responsible for the therapeutic effect. Generic prednisolone products, including those like Prednisolone Biogaran, are required by regulatory bodies to meet the same official quality standards and performance requirements as any brand-name equivalent.


Q: Can Prednisolone Biogaran cause trouble sleeping?

Yes, trouble sleeping, or insomnia, is a documented side effect of this medication. It is listed in official product information under the classification of Nervous and Psychiatric adverse reactions.


Q: Will I feel different right away after starting Prednisolone Biogaran?

The onset of action is generally rapid, but how a person feels initially can vary. While the desired anti-inflammatory effects may begin quickly, official labels indicate that some individuals may also notice certain side effects early in treatment, such as nervousness or mood changes.


Q: What are some common skin side effects associated with Prednisolone Biogaran?

Official regulatory documents list several potential skin-related side effects. These include impaired wound healing, the development of thin and fragile skin, and an increased tendency for bruising (petechiae and ecchymoses).


Q: Are there research studies looking at long-term use of Prednisolone Biogaran?

Yes, regulatory documents reference research studies conducted to evaluate the effects and safety profiles of different treatment regimens. This includes research focused on the effects of a prolonged duration or long-term use of the drug, particularly in the management of chronic diseases.


Q: Is Prednisolone Biogaran used for allergies?

Yes, prednisolone is included in official indications for the treatment of certain types of allergic disorders. This can include the management of severe, acute allergic reactions in a clinical setting.


Q: Is it safe to drink coffee or tea while taking Prednisolone Biogaran?

Caffeine in coffee or tea is not known to cause a direct, formal drug-to-drug interaction with prednisolone. However, official cautions note that high caffeine intake might potentially worsen certain common side effects of the medication, such as insomnia or elevated blood pressure.


Q: Is fatigue a common experience when taking Prednisolone Biogaran?

While regulatory documents list unusual tiredness or weakness as a potential symptom of adverse effects or adrenal gland changes, general fatigue is not consistently documented as a common, isolated side effect in core regulatory sources.


Q: What if I forget to take a dose of Prednisolone Biogaran?

Official administration rules state that a missed dose should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely and the regular schedule resumed, and taking a double dose is not advised in this situation.


Q: Is the 'Biogaran' part of the name important, or is it just the brand?

The name indicates that the active drug entity is prednisolone. Biogaran is the name of the company or pharmaceutical group that manufactures and markets this specific formulation of the prednisolone preparation. It signifies the source of the medicine.


Q: Does Prednisolone Biogaran affect blood pressure?

Yes, official safety information indicates that the medicine can affect blood pressure. Hypertension (high blood pressure) is listed as a documented side effect, which is sometimes connected to the drug’s potential to cause fluid retention.


Q: Are there any restrictions on driving or operating machinery while taking Prednisolone Biogaran?

There is no general blanket restriction; however, regulatory documents list side effects such as dizziness, vertigo, and vision changes. These types of effects have the potential to impact a person’s ability to operate machinery or drive.


Q: Is Prednisolone Biogaran used to treat asthma attacks?

Yes, regulatory indications confirm that prednisolone is used in a clinical setting for the treatment of severe, acute exacerbations of conditions like asthma.


Q: What are the general research findings on the benefits of prednisolone?

Research findings, as summarized in regulatory overviews, consistently confirm the drug's powerful anti-inflammatory and immunosuppressive effects across various conditions. The research focuses on balancing these significant therapeutic benefits against the potential for side effects related to the dose and duration of treatment.


Q: Does Prednisolone Biogaran affect eye health or vision?

Yes, official safety labeling documents potential ophthalmic effects on eye health. These include the potential development of posterior subcapsular cataracts and glaucoma (increased pressure inside the eye), particularly when the medication is used long-term.


Q: Is there a maximum time frame for safely using Prednisolone Biogaran?

Official information does not specify a single, maximum time frame for use; instead, the duration of treatment is determined by the specific condition being addressed. The governing principle in clinical practice is to utilize the lowest effective dose for the shortest possible time necessary to manage the condition.


Q: How is the effect of Prednisolone Biogaran different from non-steroidal anti-inflammatory drugs (NSAIDs)?

Prednisolone is a glucocorticoid, a type of steroid that exerts its effects primarily by altering gene expression in cells and modulating the overall immune response. This mechanism of action is distinctly different from NSAIDs, which work by blocking specific enzymes in the inflammation pathway without broadly affecting immune function.


Q: Is Prednisolone Biogaran used for autoimmune diseases?

Yes, prednisolone is officially indicated for the treatment of many different types of autoimmune disorders. Its role as an immunosuppressant helps control conditions where the body's immune system mistakenly attacks its own tissues.


Q: Can it be used to help with joint pain?

Prednisolone is indicated for the treatment of inflammatory conditions, including those that involve significant joint pain. For example, it is specifically indicated for conditions such as rheumatoid arthritis.


Q: Does Prednisolone Biogaran cause a metallic taste in the mouth?

Changes in the sense of taste, including an unpleasant or altered taste (dysgeusia), have been reported in association with the use of steroids. While not universally documented, these taste disturbances can be part of the side effect profile.


Q: Are there any major drug categories that Prednisolone Biogaran is known to interact with?

Yes, official labeling notes interactions with several major drug categories. These include medicines that affect the body’s breakdown of the drug (CYP3A4 inhibitors/inducers), certain anticoagulants, antidiabetic agents, and non-steroidal anti-inflammatory drugs (NSAIDs).

Advertisements

How should Prednisolone Biogaran be stored and disposed of?

How to Store and Dispose of Prednisolone Biogaran?

Prednisolone preparations must be stored at a temperature not exceeding 25°C and kept away from excess heat and moisture. To maintain stability, the medicine must be protected from light and stored in its tightly closed, original container.

  • The medicine must be kept strictly out of the sight and reach of children.

  • The oral solution formulation must not be refrigerated or frozen and must be discarded 120 days after first opening the bottle.

Any unused or expired product should be disposed of in accordance with local requirements. The medication should not be disposed of via wastewater or household refuse. Official guidelines recommend using a drug take-back option when available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednisolone Biogaran found in:

A-Z Index: